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Device-associated  hospital-acquired  infections  (DA-
HAI) are  deﬁned  by  the  Centers  for  Disease  Control
and Prevention’s  (CDC’s)  National  Healthcare  Safety
Network (NHSN)  as  infections  acquired  in  a hospi-
tal by  a  patient  who  was  admitted  for  a reason
other than  that  infection  [1,2].  DA-HAIs  occur
worldwide and  affect  both  developed  and  resource-
poor countries.  In  general,  the  rates  of  DA-HAIs
in intensive  care  units  (ICUs)  are  several  times
higher than  other  hospital  wards.  For  DA-HAIs,
the immune  status  of  patients  who  are  admit-
ted to  ICUs  and  usage  of  healthcare  accessory
devices are  the  main  risk  factors  [3].  ICU  staff
and physicians  could  serve  as  vehicles  that  are
A
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15;  accepted  3  April  2015
 health  care-acquired  infections  (DA-HAIs)  pose  a  threat
ly  in  the  intensive  care  unit  (ICU).  However,  few  data
heir  associated  bacterial  resistance  in  ICUs  from  Iran  are
nce  study  was  conducted  in  six  adult  and  pediatric  ICUs
als  in  Tehran  using  CDC/NHSN  deﬁnitions.  We  collected
evice  use,  DA-HAI  rates,  and  lengths  of  stay  from  2584
om  one  adult  ICU,  and  bacterial  proﬁles  and  bacterial
ng  the  DA-HAIs,  there  were  5.84  central  line-associated
s)  per  1000  central  line-days,  7.88  ventilator-associated
echanical  ventilator-days  and  8.99  catheter-associated
TIs)  per  1000  urinary  catheter-days.  The  device  utiliza-
ntral  lines,  0.42  for  mechanical  ventilators  and  1.0  for
 utilization  ratios  of  mechanical  ventilators  and  urinary
ose  reported  in  the  ICUs  of  the  INICC  and  the  CDC’s  NHSN
as  lower.  The  DA-HAI  rates  in  this  study  were  higher  than
ver,  compared  with  the  INICC  report,  the  VAP  rate  in  our
AB  rate  was  similar  and  the  CAUTI  rate  was  higher.  Nearly
mixed-type  infection.  The  most  frequent  pathogens  were
aphylococcus  aureus  and  Pseudomonas  aeruginosa, fol-
iae  and  Enterococcus  spp.  In  the  S.  aureus  isolates,  100%
verall  resistances  of  A.  baumannii  and  K.  pneumonia  to
.7%,  respectively.  A  multiple  drug  resistance  phenotype
he  isolates.  The  DA-HAI  rates  in  Iran  were  shown  to  be
tes  and  similar  to  the  INICC  rates.  Resistance  to  oxacillin
well.  Comparing  device  use,  DA-HAI  rates,  and  bacterial
olated  bacteria  indicated  a  direct  association  between
 rates  of  CAUTI.
ziz  University  for  Health  Sciences.  Published  by  Elsevier
nvolved  in  spreading  resident  pathogens  from  dif-
erent wards  of  hospital  to  the  ICUs  [4].  Hospital
nvironments can  serve  as  major  reservoirs  of
ain bacterial  pathogens,  such  as  methicillin  resis-
ant Staphylococcus  aureus  (MRSA),  vancomycin
esistant Enterococci  (VREs),  carbapenem  resistant
lebsiella  spp.,  Acinetobacter  spp.  or  Pseudomonas
pp., and  Gram  positive  or  Gram  negative  bacteria
hat present  with  multidrug  resistant  (MDR)  pheno-
ypes. The  emergence  of  MDR  bacteria  responsible
or DA-HAIs  is  considered  to  be  a major  problem  in
ost hospitals.  Annually  surveying  the  rates  of  DA-
AIs in  hospitalized  patients  in  ICUs  is  essential. decrease  in  DA-HAIs  could  be  achieved  through
he detection  of  the  primary  responsible  pathogens
nd their  resistance  patterns  for  successful  ther-
py.
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sevice  associated  infection  and  bacterial  resistance
In  Asian  countries,  Pseudomonas  aeruginosa,
lebsiella spp.,  Escherichia  coli,  Enterococci,
nd S.  aureus  are  among  the  most  frequent
athogenic  bacteria  in  the  ICUs.  Imipenem  resis-
ant P.  aeruginosa, third-generation-cephalosporin-
esistant K.  pneumonia  and  Acinetobacter  bauman-
ii, methicillin-resistant  S.  aureus,  and  quinolone-
esistant E.  coli  are  among  the  most  common
esistant strains  that  show  a  MDR  resistance  pattern
n these  countries  [5]. In  a  previous  study,  hospital-
zed  patients  in  the  Middle  East  had  a  greater  risk  of
ontracting  DA-HAIs  (72.6%)  compared  with  other
ountries  [6].  The  least  active  agents  against  the
oted bacteria  in  these  countries  were  reported  to
e ceftriaxone,  ceftazidime  and/or  cefepime.
Because  of  the  high  morbidity  and  mortality
f DA-HAIs  in  Iran  and  the  paucity  of  information
egarding the  types  and  resistance  patterns  of  these
athogens,  we  report  a  summary  of  the  data  on  DA-
AIs collected  in  6  intensive  care  units  (ICUs)  in  6
ranian hospitals  from  Tehran  between  August  2011
nd October  2012.
This  study  aimed  to  analyze  the  occurrence  of
A-HAIs  in  the  ICUs  of  six  different  hospitals  and
ompare  them  against  the  International  Nosoco-
ial Infection  Control  Consortium  (INICC)  [7]  andhe Centers  for  Disease  Control  and  Prevention’s
ational Healthcare  Safety  Network  (NHSN)  bench-
ark reports  [8]  to  compare  the  rates  of  device
s
r
[
w
Table  1  Device-associated  infections  and  length  of  stay  in
Number  of  patients,  n  
Number  of  bed  days,  n  
Central  line  days,  n  
LOS  of  patients  without  HAI  
Mechanical  ventilator  days,  n  
Urinary  catheter  days,  n  
Use  of  central  line,  rate  (95%  CI)  
Use  of  mechanical  ventilator,  rate  (95%  CI)  
Use  of  urinary  catheter,  rate  (95%  CI)  
CLABSI,  n  
CLABSI  per  1000  central  line  days  (95%  CI)  
LOS  of  patients  with  CLABSI  
VAP,  n  
VAP  per  1000  mechanical  ventilator  days  (95%  CI)  
LOS  of  patients  with  VAP  
CAUTI,  n  
CAUTI  per  1000  urinary  catheter  days  
LOS  of  patients  with  CAUTI  
Overall  device-associated  infections  %  (95%  CI)  
Overall  device-associated  infections  by  1000  bed  days  (95%  
CI, conﬁdence interval; CLABSI, central line-associated bloodstream
VAP, ventilator-associated pneumonia.
LOS, length of stay; DA-HAI, device-associated healthcare-acquiredsix  hospitals  of Iran  555
se  (DU),  DA-HAI,  and  bacterial  resistance  for  the
rimary isolated  bacteria.  The  goal  of  this  study
as to  identify  the  most  important  responsible  bac-
erial pathogens  and  their  resistance  proﬁles  in
ehran, Iran.  Furthermore,  this  was  the  ﬁrst  study
n Iran  that  sought  to  ﬁnd  any  possible  associations
etween the  types  of  colonized  bacteria  in  medical
evices and  those  isolated  from  patients’  clinical
pecimens.
ethods
tudy setting and design
his  prospective  cohort  surveillance  study  was  con-
ucted in  6  ICUs  in  6  medium-sized  academic
ospitals from  Tehran,  Iran.  Prospective  surveil-
ance was  conducted  on  health  care-acquired
nfections  and  related  factors,  including  the  fol-
owing classiﬁed  into  speciﬁc  module  protocols:
xcess length  of  stay  (LOS),  crude  excess  length
f stay,  microbiological  proﬁle,  bacterial  resis-
ance,  and  antimicrobial  use.  All  DA-HAIs  and
urgical site  infections  (SSIs)  were  categorized  using
tandard CDC-NHSN  deﬁnitions  that  included  labo-
atory tests,  radiology  tests,  and  clinical  criteria
1]. Laboratory-conﬁrmed  bloodstream  infections
ere  recorded  and  reported  [1].
 ICU-I.
August  2011—September  2012
2584
16,796
7364
4.8  (4.6—4.9)
6976
16,796
0.44  (0.43—0.45)
0.42  (0.41—0.42)
1.0  (1.0—1.0)
43
5.84  (4.2—7.9)
28.3  (21.2—39.0)
55
7.88  (5.9—10.3)
25.5  (18.6—34.7)
151
8.99  (7.6—10.5)
12.9  (11.0—15.1)
9.6%  (8.5—10.3)
CI)  14.8  (13.0—17.0)
 infection; CAUTI, catheter-associated urinary tract infection;
 infection.
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Data collection
Infection  control  professionals  (ICPs)  collected  data
on central  line-associated  bloodstream  infections
(CLABs), catheter-associated  urinary  tract  infec-
tions (CAUTIs),  ventilator-associated  pneumonias
(VAPs) and  SSIs  occurring  in  patients  hospitalized
in a  speciﬁc  patient-care  location.  The  ICUs  were
stratiﬁed according  to  the  type  of  patient  as  fol-
lows: adult,  pediatric  or  neonatal.
The ICPs  from  the  6  participating  hospitals  had
previous experience  conducting  DA-HAI  surveil-
lance and  sent  detailed  and  aggregated  data  to  the
INICC Headquarters  in  Buenos  Aires,  Argentina.  The
DA-HAI rates,  device  use  and  length  of  stay  were
analyzed in  one  of  the  six  ICUs  (ICU-I).  The  bacte-
rial proﬁle  and  bacterial  resistance  were  analyzed
in the  six  ICUs  included  in  this  study.
Data analysis
Device-days  consisted  of  the  total  number  of  cen-
tral line  (CL)-days,  urinary  catheter  (UC)-days,  or
ventilator days.
Crude excess  LOS  of  DA-HAI  equaled  the  crude
LOS of  ICU  patients  with  DA-HAI  minus  the  crude
LOS of  patients  without  DA-HAI.
EpiInfo® version  6.04b  (CDC,  Atlanta,  GA)  and
SPSS 16.0  (SPSS  Inc.  an  IBM  company,  Chicago,  Illi-
nois) were  used  to  conduct  data  analysis.  Relative
risk (RR)  ratios,  95%  conﬁdence  intervals  (CIs)  and
P-values were  determined  for  the  primary  and  sec-
ondary outcomes.
Results
The  ICUs  from  Iran  belonged  to  six  different  public
academic teaching  hospitals.  The  length  of  partici-
pation of  the  hospitals  in  this  study  was  one  year.  We
calculated  the  DA-HAI  rates,  DU  ratios  and  LOS  in
one of  the  ICUs  (ICU-I)  and  compared  them  with  the
INICC global  results  and  the  CDC-NHSN.  The  bacte-
rial proﬁle  and  bacterial  resistance  were  calculated
in the  six  participant  ICUs  and  were  also  compared
with INICC  and  CDC-NHSN.
Table  1  shows  the  DA-HAI  rates,  LOS  and  DU  ratios
according  to  the  infection  types  (CLABSI,  CAUTI,
and VAP);  the  Outcome  Surveillance  component  was
fully implemented.  The  UC  had  an  extremely  high
DU rate  (1.0).  CAUTI  was  also  the  most  common  DA-
HAI, with  a  rate  of  8.99  per  1000  UC-days.  Of  the
UTIs, 82.9%  (151  out  of  182)  were  related  to  UCs,
78.5% (55  out  of  70)  of  the  pneumonias  were  related
to mechanical  ventilators,  and  93.4%  (43  out  of  46) T
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Table  3  Frequency  of  the  bacterial  pathogens  responsible  for  the  single  and  mixed  type  infections  in  HAIs  from
the  six  participating  ICUs.
Bacterial  pathogens  No.  of
isolated
pathogens
Urinary
tract
infection
Bloodstream
infection
Surgical
site
infection
Pneumonia Mixed  type
infection
rates  Na (%)
Staphylococcus  aureus 33 0/0  1/1  1/6  26/26  28  (12.2)
Enterococcus  spp. 20  8/8  4/4  1/5  0/3  13  (5.6)
Pseudomonas  aeruginosa 33  5/5  2/2  5/7  19/19  31  (13.5)
Acinetobacter  baumannii 76  2/3  3/4  4/9  54/60  63  (27.5)
Staphylococcus  epidermidis  6  1/2  1/2  0/0  2/2  4  (1.7)
Bacillus  spp.  5  1/1  0/0  0/0  4/4  5  (2.2)
E.  coli  7  1/1  0/0  0/3  3/3  4  (1.7)
Citrobacter  spp.  1  0/0  0/0  0/0  1/1  1  (0.4)
Enterobacter  spp.  2  0/0  0/0  0/1  1/1  1  (0.4)
Klebsiella  pneumoniae  25  3/3  1/1  6/6  15/15  25  (11)
Proteus  spp.  5  1/1  0/0  1/1  3/3  5  (2.2)
Streptococcus  spp.  1  0/0  0/0  0/0  0/1  0  (0)
Burkholderia  spp.  1  0/0  0/0  0/0  0/1  0  (0)
Total  180/215
(83.7)
a N indicates the number of each isolated bacterial genus among samples from 228 patients with suspected HAIs. The number
the s
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aof mixed type infection/total number of infections caused by 
f  the  bloodstream  infections  were  related  to  cen-
ral lines.  The  data  presented  also  include  the  crude
OS of  patients  hospitalized  in  the  same  ICU  dur-
ng the  surveillance  period  with  and  without  DA-HAI
nd the  crude  excess  length  of  stay  of  patients  with
LABSI,  CAUTI,  and  VAP.  The  VAP  presented  with  the
ighest LOS  (30  days).
Table  2  compares  the  rates  and  DU  of  this  ICU
rom Iran  with  the  INICC  international  report  for  the
eriod from  2007  to  2012  and  the  2012  CDC-NHSN
eport [2].
Table  3  provides  data  on  the  frequency  of  bac-
erial pathogens  in  the  six  ICUs  from  the  Iranian
ospitals stratiﬁed  by  types  of  the  infections.  The
ost frequent  pathogens  were  S.  aureus  and  P.
eruginosa, followed  by  Klebsiella  pneumoniae  and
nterococcus  spp.
Table  4  provides  data  on  the  bacterial  sensi-
ivity patterns  in  the  six  ICUs  stratiﬁed  by  the
ypes of  the  infections.  We  found  a high  over-
ll resistance  to  oxacillin,  amoxicillin-clavulanate,
nd  cefotaxime.  The  lowest  resistance  was  found
or vancomycin,  which  was  identiﬁed  as  the  most
ffective  drug  among  the  15  tested  antibiotics
gainst these  bacteria  at  laboratory  conditions.
Table  5  presents  the  frequency  of  antimicrobial
esistance  rates  to  the  most  commonly  prescribed
ntibiotics for  DA-HAIs  in  the  six  ICUs  studied.  We
ound that  the  resistance  to  oxacillin  was  100%  in
oth the  strains  of  S.  aureus  related  to  pneumonia
nd overall.  The  overall  resistance  of  A.  bauman-
ii and  K.  pneumoniae  to  imipenem  was  70.5%
[
w
p
1ame pathogen in HAIs are represented separately.
nd  76.7%,  respectively.  The  MDR  phenotype  was
etected  in  68.15%  of  the  isolated  bacteria  from
he clinical  samples.  The  MDR  phenotype  was  most
ommon  in  A.  baumannii  (67  out  of  67;  100%),  fol-
owed by  S.  aureus  (14  out  of  17;  82%),  Klebsiella
pp. (13  out  of  16,  81%),  Enterococcus  spp.  (18
ut of  22,  82%),  E.  coli  (3  out  of  6,  50%),  and  P.
eruginosa (12  out  of 26;  46%).
Finally, Table  6 compares  the  resistance  rates  in
athogens  associated  with  urinary  tract  infections
n the  six  ICUs  of  this  study  with  CDC-NHSN  [3]  and
NICC rates  [7]. We  found  that  oxacillin  resistance
o S.  aureus  was  higher  in  this  study  than  in  the
NICC and  CDC  reports.  Similarly,  the  resistance  of
. baumannii  to  imipenem  was  higher  than  in  these
eports.
iscussion
everal  studies  have  shown  that  the  DA-HAIs  are  an
mportant  issue  in  Iran.  Afhami  et  al.  found  that
AP was  the  most  common  infection  in  ICUs,  and
he rate  per  1000  MV  days  was  9.96,  which  is  sim-
lar to  our  7.88  rate  [4].  However,  in  this  study,
AUTI was  the  most  common  DA-HAI.  A study  by
skarian  et  al.  showed  that  the  highest  LOS  was
ssociated  with  bloodstream  infections  (9.2  days)
5]. In  our  study,  the  highest  LOS  was  associated
ith VAP  (25  days)  and  the  overall  length  of  stay  of
atients  with  DA-HAI  was  higher  (ranging  between
3 and  25  days).  In  a study  conducted  in  one
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oS.  Jahani-Sherafat  et  al.
ospital  in  Iran,  Mohammadtaheri  et  al.  found  a
igh rate  of  bacterial  resistance  (96.2%),  particu-
arly oxacillin/methicillin  resistance  to  S.  aureus
6]. In  our  study,  100%  of  the  isolates  were  resistant
o oxacillin.  In a  recent  study  by  Tao  et  al.  in  2012
n China,  the  three  main  pathogens  A.  baumannii
29%), P.  aeruginosa  (16%),  and  S.  aureus  (18%)  were
eported to  be  the  main  isolated  microorganisms  in
AP [9].  A  study  by  Leblebicioglu  et  al.  in  2007  in
urkey showed  that  54.5%  of  VAP  cases  were  caused
y Acinetobacter  spp.,  14.9%  by  Pseudomonas  spp.,
1.9% by  S.  aureus  and  7.9%  by  Enterobacteriaceae
10]. The  results  of  our  study  also  showed  the  same
acteria  as  the  most  frequent  pathogens  isolated
rom patients  with  pneumonia  and  a  history  of  ven-
ilation (Acinetobacter  spp.  [60%],  P.  aeruginosa
19%], and  S.  aureus  [26%]).  Acinetobacter  spp.,
. aeruginosa  and  S.  aureus  were  similarly  consid-
red to  be  the  most  prevalent  pathogens  causing
SI. However,  in  a  report  by  Hidron  et  al.  on  7025
SI samples,  Coagulase-negative  Staphylococci  and
. aureus  were  identiﬁed  to  be  the  most  prevalent
athogens in  SSI  [8].  Vancomycin-resistant  Entero-
occi (VRE)  showed  a  prevalence  rate  of  24.5%,
hich was  lower  than  that  reported  by  Hidron  et  al.
54.5%) [8]. The  resistance  rates  of  P.  aeruginosa
o piperacillin  were  near  to  those  reported  by
he INICC  in  2006—2007  (15.9—33.8%)  but  higher
han those  reported  by  NHSN  in  2009—2010  (16.6%)
7,8].  Our  results  showed  higher  resistance  rates
or E.  coli,  Acinetobacter  spp.  and  K.  pneumo-
ia compared  with  studies  performed  in  Taiwan
nd Pakistan  [11,12].  Among  the  studied  bacte-
ia, A.  baumannii  exhibited  the  highest  level  of
acterial  resistance  to  all  of  the  tested  agents.
s this  bacterium  presented  frequently  in  mixed
ype infections,  this  increased  level  of  resistance
ould be  explained  by  the  acquisition  of  resistance
enes from  other  bacteria.  Finally,  the  interna-
ional benchmarks  of  bacterial  resistance  rates  in
athogens  related  to  CAUTI  in  the  six  ICUs  of
his study  showed  that  the  patterns  of  resistance
f oxacillin  to  S.  aureus  and  of  A.  baumannii  to
mipenem  were  higher  in  this  study  than  both  the
NICC [7]  and  CDC  rates  [3].
The most  signiﬁcant  ﬁnding  in  our  study  was
hat the  rates  of  DU,  DA-HAI,  and  bacterial  resis-
ance for  the  primary  isolated  bacteria  indicated
 direct  association  between  urinary  catheter  use
nd the  rates  of  CAUTI.  This  ﬁnding  revealed  that
A-UTI,  particularly  CAUTI,  in  the  ICUs  of  Tehran
oses  a greater  threat  to  patients’  safety.  How-
ver, colonization  of  the  most  common  bacteria  in
hese devices  was  not  associated  with  the  rates  of
acterial resistance  because  the  resistance  rates
f strains  of  P.  aeruginosa  and  Enterococcus  spp.
Device  associated  infection  and  bacterial  resistance  in  six  hospitals  of Iran  559
Table  5  Frequency  of  the  antimicrobial  resistance  rates  to  their  most  frequently  associated  prescribed  antibiotics
for  their  infections  in  the  six  intensive  care  units  of  the  studied  hospitals.
Pathogen/antimicrobial  Resistance  (%)
Pneumonia  Surgical  site
infection
Bloodstream
infection
Urinary  tract
infection
Total
E.  coli  —  —  —  —
Imipenem  100  0  —  66.7  41.7
Pseudomonas  aeruginosa  —  —  —  —
Cefepime  33.3  57.1  0  53.3  36
Piperacillin  33.3  28.6  0  33.3  23.8
Imipenem  33.3  57.1  46.7  0  34.3
Klebsiella  pneumoniae — —  —  —
Imipenem  100  80  0  50  76.7
Enterococcus  spp.  —  —  —  —
Vancomycin  50  33.3  —  10  23.2
Staphylococcus  aureus  —  —  —  —
Oxacillin  100  100  —  —  100
Acinetobacter  baumannii  —  —  —  —
 
t
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tImipenem  —  85.7
hat  are  frequently  isolated  from  the  urine  and
atheters  of  patients  with  CAUTI  were  lower  than
ther  clinical  samples.  This  association  appears  to
e related  to  their  ability  to  form  a  bioﬁlm  in  these
evices.
Our study  has  a  number  of  limitations,  includ-
ng incompletely  reported  data  by  the  hospital
nfection control  departments  in  some  of  the  par-
icipating  hospitals  during  the  study  period.  The
econd limitation  was  the  lack  of  data  regarding
ntibiotic prescriptions  in  each  ICU  to  assess  any
ssociation  between  the  antibiotic  consumption
nd the  HAIs  caused  by  the  MDR  bacteria  colonizing
he medical  devices.
T
a
l
a
Table  6  Comparison  with  the  International  Nosocomial  I
Control  and  Prevention’s  National  Healthcare  Safety  Network
related  to  urinary  tract  infections.
Pathogen/antimicrobial  Resistance  (%)
This  study  
E.  coli
Imipenem  66.7  
Pseudomonas  aeruginosa
Piperacillin  33.3  
Imipenem  0.0  
Klebsiella  pneumoniae
Imipenem  50.0  
Staphylococcus  aureus
Oxacillin  100.0  
Acinetobacter  baumannii
Imipenem  96.4  
INICC, International Nosocomial Infection Control Consortium; CDC
Healthcare Safety Network.100  96.4  70.5
In  conclusion,  the  data  presented  in  this  report
upport that  DA-HAIs  in  Iran  pose  a  grave  and  fre-
uently concealed  risk  to  patient  safety  compared
ith the  developed  world.  More  research  needs  to
e conducted  to  show  the  association  between  the
ncidence  of invasive  DU  in  these  ICUs  and  its  role
n DA-HAIs.  Our  main  goal  should  be  to  enhance
nfection control  practices  by  facilitating  elemen-
al, feasible  and  inexpensive  tools  and  resources  to
ackle this  problem  effectively  and  systematically.
hese practices  would  lead  to  greater  and  stricter
dherence  to  infection  control  programs  and  guide-
ines with  correlated  reductions  in  DA-HAI  and  its
dverse  effects.
nfection  Control  Consortium  and  Centers  for  Disease
 reports  for  the  resistance  rates  of  pathogenic  bacteria
INICC  2007—2012  NHSN  CDC  2009—2010
5.1  2.3
37  16.6
33.5  21.3
13.9  12.5
36.4  58.7
67.7  74.2
-NHSN, Centers for Disease Control and Prevention’s National
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